HSK16149

oral, brain-penetrant VGCC inhibitor

Ph. II/III for diabetic neuropathic pain in China

gabapentenoid

J. Pharmacol. Exp. Ther., Mar. 1, 2021

Haisco Pharmaceutical, Chengdu, CN

10. The Haisco voltage-gated calcium channel (VGCC) alpha-2-delta subunit inhibitor, HSK16149, is a potent and potentially longer-acting gabapentinoid drug candidate for chronic pain over pregabalin, with a potentially wider…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.